BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 31383001)

  • 1. PLCε regulates prostate cancer mitochondrial oxidative metabolism and migration via upregulation of Twist1.
    Fan J; Fan Y; Wang X; Niu L; Duan L; Yang J; Li L; Gao Y; Wu X; Luo C
    J Exp Clin Cancer Res; 2019 Aug; 38(1):337. PubMed ID: 31383001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipase Cε Regulates Prostate Cancer Lipid Metabolism and Proliferation by Targeting AMP-Activated Protein Kinase (AMPK)/Sterol Regulatory Element-Binding Protein 1 (SREBP-1) Signaling Pathway.
    Zheng Y; Jin J; Gao Y; Luo C; Wu X; Liu J
    Med Sci Monit; 2020 Jul; 26():e924328. PubMed ID: 32696762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
    Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
    Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression.
    Hu J; Tian J; Zhu S; Sun L; Yu J; Tian H; Dong Q; Luo Q; Jiang N; Niu Y; Shang Z
    Br J Cancer; 2018 Jan; 118(1):88-97. PubMed ID: 29123266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of Phospholipase Cε (PLCε) Inhibits Cell Proliferation via Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN)/AKT Signaling Pathway in Human Prostate Cancer.
    Wang X; Fan Y; Du Z; Fan J; Hao Y; Wang J; Wu X; Luo C
    Med Sci Monit; 2018 Jan; 24():254-263. PubMed ID: 29330357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLCε regulates metabolism and metastasis signaling via HIF-1α/MEK/ERK pathway in prostate cancer.
    Fan Y; Ou L; Fan J; Li L; Wang X; Niu L; Wu X; Luo C
    J Cell Physiol; 2020 Nov; 235(11):8546-8557. PubMed ID: 32383180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The twist box domain is required for Twist1-induced prostate cancer metastasis.
    Gajula RP; Chettiar ST; Williams RD; Thiyagarajan S; Kato Y; Aziz K; Wang R; Gandhi N; Wild AT; Vesuna F; Ma J; Salih T; Cades J; Fertig E; Biswal S; Burns TF; Chung CH; Rudin CM; Herman JM; Hales RK; Raman V; An SS; Tran PT
    Mol Cancer Res; 2013 Nov; 11(11):1387-400. PubMed ID: 23982216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1.
    Alexander NR; Tran NL; Rekapally H; Summers CE; Glackin C; Heimark RL
    Cancer Res; 2006 Apr; 66(7):3365-9. PubMed ID: 16585154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
    Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
    Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLCε knockdown inhibits prostate cancer cell proliferation via suppression of Notch signalling and nuclear translocation of the androgen receptor.
    Wang Y; Wu X; Ou L; Yang X; Wang X; Tang M; Chen E; Luo C
    Cancer Lett; 2015 Jun; 362(1):61-9. PubMed ID: 25796442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twist1 and AP-1 cooperatively upregulate integrin α5 expression to induce invasion and the epithelial-mesenchymal transition.
    Nam EH; Lee Y; Moon B; Lee JW; Kim S
    Carcinogenesis; 2015 Mar; 36(3):327-37. PubMed ID: 25600770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells.
    Gajula RP; Chettiar ST; Williams RD; Nugent K; Kato Y; Wang H; Malek R; Taparra K; Cades J; Annadanam A; Yoon AR; Fertig E; Firulli BA; Mazzacurati L; Burns TF; Firulli AB; An SS; Tran PT
    Neoplasia; 2015 Jan; 17(1):16-31. PubMed ID: 25622896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-Derived Ets Factor (PDEF) Inhibits Metastasis by Inducing Epithelial/Luminal Phenotype in Prostate Cancer Cells.
    Wang F; Koul S; Shanmugam PST; Dong Q; Koul HK
    Mol Cancer Res; 2018 Sep; 16(9):1430-1440. PubMed ID: 29848555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer.
    Ezponda T; Popovic R; Shah MY; Martinez-Garcia E; Zheng Y; Min DJ; Will C; Neri A; Kelleher NL; Yu J; Licht JD
    Oncogene; 2013 Jun; 32(23):2882-90. PubMed ID: 22797064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new PKCα/β/TBX3/E-cadherin pathway is involved in PLCε-regulated invasion and migration in human bladder cancer cells.
    Du HF; Ou LP; Yang X; Song XD; Fan YR; Tan B; Luo CL; Wu XH
    Cell Signal; 2014 Mar; 26(3):580-93. PubMed ID: 24316392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR186 suppresses prostate cancer progression by targeting Twist1.
    Zhao X; Wang Y; Deng R; Zhang H; Dou J; Yuan H; Hou G; Du Y; Chen Q; Yu J
    Oncotarget; 2016 May; 7(22):33136-51. PubMed ID: 27121312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
    Zhang X; Wang Y; Ning Y
    Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TWIST1-WDR5-
    Malek R; Gajula RP; Williams RD; Nghiem B; Simons BW; Nugent K; Wang H; Taparra K; Lemtiri-Chlieh G; Yoon AR; True L; An SS; DeWeese TL; Ross AE; Schaeffer EM; Pienta KJ; Hurley PJ; Morrissey C; Tran PT
    Cancer Res; 2017 Jun; 77(12):3181-3193. PubMed ID: 28484075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLCε knockdown enhances the radiosensitivity of castration‑resistant prostate cancer via the AR/PARP1/DNA‑PKcs axis.
    Pu J; Li T; Liu N; Luo C; Quan Z; Li L; Wu X
    Oncol Rep; 2020 May; 43(5):1397-1412. PubMed ID: 32323799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.
    Yoshino H; Yonemori M; Miyamoto K; Tatarano S; Kofuji S; Nohata N; Nakagawa M; Enokida H
    Oncotarget; 2017 Mar; 8(13):20881-20894. PubMed ID: 28152509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.